Skip to main content
Home
Merics
Mercator Institute for China Studies

Main navigation

  • Analysis
  • Experts
  • Events
  • Services
Search

Second navigation

  • About
    • Leadership and staff
    • Governance
    • Opportunities
    • Partners
  • Media

User account menu

  • Membership Area
  • en
  • de

Main navigation

  • Analysis
  • Experts
  • Events
  • Services

Second navigation

  • About
    • Leadership and staff
    • Governance
    • Opportunities
    • Partners
  • Media

User account menu

  • Membership Area
  • en
  • de
Lab leader, market ascender: China's rise in biotechnology
Lab leader, market ascender: China's rise in biotechnology
MERICS Report
Mastodon





Share via...
  • Facebook
  • LinkedIn
  • Twitter
  • Mail
Home
Merics

US-China policy under Trump 2.0, with Thomas E. Kellogg

China Update Newsletter
MERICS Update

Sign up for our “MERICS Update” and publication alerts.

Subscribe

Become a member

As a member, you can rely on us to deepen your organization's China expertise and to help you with the most critical strategic decisions concerning China.

More information

China’s overcapacity and the EU + German China policy under Merz + EU-China trade
MERICS Briefs
Read more

Themen

  • EU-China
  • Party and state
  • Industrial Policy and Technology
  • Climate and environment
  • Geopolitics
  • Trade and Investment
  • Belt and Road
  • Hong Kong
  • Digital China

Footer (main navigation)

  • Analysis
  • Experts
  • Events
  • Services

Footer (second navigation)

  • Podcast
  • Media
  • Contact

About

  • Leadership and Staff
  • Governance
  • Opportunities
  • Partners
  • Membership Program
Lab leader, market ascender: China's rise in biotechnology
Lab leader, market ascender: China's rise in biotechnology
MERICS Report
Mastodon





Footer (legal information)

  • Privacy policy and cookies
  • Legal notice
© Mercator Institute for China Studies (Merics) gGmbH. 2025
Initiated and funded by: